W0UV28 (W0UV28_HUMAN) Homo sapiens (Human)

Angiogenin UniProtKBInterProInteractive Modelling

147 aa; Sequence (Fasta) ; 2 identical sequences: Homo sapiens: P03950; Gorilla gorilla gorilla: Q71MJ0

Available Structures

52 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of Human Angiogenin in complex with Fab fragment of its monoclonal antibody mAb 2… Heteromer
P03950;
25-147
SO4;GOL;
Assess
RIBONUCLEASE INHIBITOR-ANGIOGENIN COMPLEX Heteromer
P03950; P13489;
25-147
Assess
CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN REVEALS THE STRUCTURAL BASIS FOR ITS FUNCTIONAL DIVERGENCE FR…homo-2-mer25-147
Assess
Crystal structure of human angiogenin and RNA duplexhomo-2-mer25-147
GOL;
Assess
R121H - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysishomo-2-mer26-146
CL;
Assess
Structural snapshots and functional analysis of human angiogenin variants associated with Amyotroph…monomer24-146
TAR;TLA;
Assess
Crystal Structure of Human Angiogenin Variant Q117Gmonomer25-147
CIT;
Assess
CRYSTAL STRUCTURE OF HUMAN ANGIOGENINmonomer25-147
CIT;
Assess
CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN OF THE MET(-1) FORMmonomer25-147
CIT;
Assess
Binding of Phosphate and Pyrophosphate ions at the active site of human angiogenin as revealed by X…monomer25-147
PO4;
Assess
CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT K40Qmonomer25-147
CIT;
Assess
CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT H13A.monomer25-147
Assess
Human angiogenin ALS variant H114Rmonomer25-147
GOL;BO4;
Assess
Crystal Structure of Human Angiogenin Variant D116Hmonomer25-147
Assess
3D SOLUTION STRUCTURE OF HUMAN ANGIOGENIN DETERMINED BY 1H, 15N NMR SPECTROSCOPY, 30 STRUCTURESmonomer25-147
Assess
Human angiogenin ALS variant F100Imonomer26-147
TAR;TLA;PEG;
Assess
X-ray structure of the adduct formed upon reaction of cisplatin with human angiogenin after 5 days …monomer25-146
GOL;NH3;PT;TAR;
Assess
Binding of Phosphate and Pyrophosphate ions at the active site of human Angiogenin as revealed by X…monomer26-147
POP;
Assess
Crystal structure of human Angiogenin at 1.35 Angstroms resolutionmonomer26-146
Assess
Human angiogenin PD variant R95Qmonomer25-145
SO4;PEG;PGE;
Assess
Human angiogenin PD/ALS variant R121Cmonomer26-146
TLA;GSH;
Assess
Human Angiogenin mutant-S28Amonomer26-146
Assess
X-ray structure of the adduct formed upon reaction of oxaliplatin with human angiogeninmonomer26-146
PT;TAR;
Assess
X-ray structure of the adduct formed upon reaction of cisplatin with human angiogenin after 1 month…monomer26-146
NH3;PT;
Assess
Binding of Phosphate and Pyrophosphate ions at the active site of human Angiogenin as revealed by X…monomer27-147
CIT;PO4;
Assess
I46V - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysismonomer26-146
TAR;
Assess
CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT T80Amonomer26-146
CIT;
Assess
Human Angiogenin in complex with sulphate anions at an acidic solutionmonomer25-145
SO4;
Assess
S28N - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysismonomer26-146
TAR;
Assess
Human Angiogenin mutant-S28AT36AS37Amonomer26-145
Assess
Human angiogenin PD variant Q77Pmonomer27-146
SO4;PGE;EDO;BTB;
Assess
Crystal Structure of Human Angiogenin Variant des(121-123)monomer25-144
CIT;
Assess
Human angiogenin ALS variant T80Smonomer26-145
SO4;
Assess
Human Angiogenin in complex with sulphate anions at a basic solutionmonomer26-145
SO4;GOL;
Assess
Human angiogenin ALS variant V103Imonomer26-145
TAR;
Assess
Human angiogenin PD variant K60Emonomer26-145
TLA;
Assess
V113I - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysismonomer27-146
TLA;
Assess
K54E - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysismonomer27-146
Assess
Human angiogenin ALS variant K40Rmonomer27-146
TAR;PEG;
Assess
K17I - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysismonomer27-146
TLA;
Assess
K17E - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysismonomer26-145
SO4;EDO;
Assess
Human angiogenin PD variant K54Rmonomer26-145
TAR;PEG;
Assess
R31K - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysismonomer26-145
TLA;
Assess
ARH-II, AN ANGIOGENIN/RNASE A CHIMERAmonomer27-146
CIT;
Assess
Human Angiogenin quardruple mutant-S28AT36AS37AS87Amonomer26-145
CIT;
Assess
Crystal Structure of Human Angiogenin with an Engineered Loop Exhibits Conformational Flexibility a…monomer27-145
Assess
P112L - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysismonomer28-146
TLA;
Assess
Q12L - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysismonomer28-146
Assess
Human angiogenin PD variant H13Rmonomer28-145
TAR;
Assess
Crystal structure of human angiogenin double variant I119A/F120Amonomer27-144
Assess
K40I - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysismonomer28-145
Assess
CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT T44Dmonomer27-141
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
1hby.1.Amonomer0.8825-147
100.00
Assess